References

Schultz G., Sibbald G., Falanga V. Wound bed preparation: a systematic approach to wound management. Wound Repair Regen. 2003; 11:1-28

Sieggreen M., Malkebust J. Debridement: choices and challenges. Adv Wound Care. 1997; 10:(2)32-7

Gottrup F. Wound treatment and care.London: Campden Publishing; 1999

Hart J. Inflammation. 1: Its role in the healing of acute wounds. J Wound Care. 2002; 11:(6)205-9

Attinger C.E., Janis J.E., Steinberg Clinical approach to wounds: débridement and wound bed preparation including the use of dressings and wound-healing adjuvants. Plast Reconstr Surg. 2006; 117:S72-109

Velnar T., Bailey T., Smrkolj V. The wound healing process: an overview of the cellular and molecular mechanisms. J Int Med Res. 2009; 37:(5)1528-42

Mustoe T. Understanding chronic wounds: a unifying hypothesis on their pathogenesis and implications for therapy. Am J Surg. 2004; 187:(5A)65S-70S

Telgenhoff D., Shroot B. Cellular senescence mechanisms in chronic wound healing. Cell Death and Differentiation. 2005; 12:695-8

Gray D., White R., Cooper P. Applied wound management and using the wound healing continuum in practice. Wound Essentials. 2010; 5:131-9

Effective Debridement in a Changing NHS: A UK Consensus. Wounds UK. 2013. http://www.wounds-uk.com/supplements/effective-debridement-in-a-changing-nhs-a-uk-consensus

Percival S.L., Suleman L. Slough and biofilm: removal of barriers to wound healing by desloughing. J Wound Care. 2015; 24:(11)498-510

Grothier L. Improving clinical outcomes and patient experience through the use of desloughing. Br J Comm Nurs. 2015; 29:S25-31

Fonseca A. Biofilms in wounds: An unsolved problem?. EWMA Journal. 2011; 11:(2)10-8

Wolcott R.D., Rhoads D.D., Dowd S.E. Biofilms and chronic wound inflammation. J Wound Care. 2008; 17:(8)333-41

Rhoads D.D., Wolcott R.D., Percival S.L. Biofilms in wounds: management strategies. J Wound Care. 2008; 17:(11)502-8

Phillips P.L., Wolcott R.D., Fletcher J. Biofilms made easy. Wounds International. 2010; 1:(3)1-6

Hurlow J., Bowler P.G. Clinical experience with wound biofilm and management: a case series. Ostomy Wound Manage. 2009; 55:(4)38-49

European Wound Management Association Wound bed preparation in practice. 2004. http://old.ewma.org/english/publications/ewmadocuments-and-articles/position-documents/alldocuments.html

Schultz G., Dowsett C. Wound bed preparation revisited. Wounds International. 2012; 3:(1)27-9

National Institute for Health and Care Excellence Guidance on the use of debriding agents and specialist wound care clinics for difficult to heal surgical wounds. 2001. https://www.nice.org.uk/guidance/ta24

Ayello E., Cuddigan J. Debridement: controlling the necrotic/cellular burden. Adv Skin Wound Care. 2004; 17:(2)66-75

Strohal R., Apelqvist J., Dissemond J. EWMA Document: Debridement. J Wound Care. 2013; 22:S1-52

Lewis R., Whiting P., ter, Riet G. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of debriding agents in treating surgical wounds healing by secondary intention. Health Technol Assess. 2001; 5:(14)1-131

Cowan T. Is there a difference between debridement and desloughing?. Br J Nurs. 2015; 24:S18-20

Ayello E., Baranoski S., Kerstein M. Wound Debridement. In: Baranoski S., Ayello E. (eds). Philadelphia: Lippincott Williams and Wilkins; 2004

Davies P. Current thinking on the management of necrotic and sloughy wounds. Prof Nurse. 2004; 19:(10)34-6

Baharestani M. The clinical relevance of debridement. In: Baharestani M., Gottrup F., Holstein P., Vanscheidt W. (eds). New York: Springer Verlag; 1999

National Institute for Health and Care Excellence Medical Technology guidance: the Debrisoft monofilament debridement pad for use un acute or chronic wounds (MTG 17). The Debrisoft monofilament debridement pad for use un acute or chronic wounds (MTG 17). 2014. https://www.ncbi.nlm.nih.gov/pubmed/?term=The+Debrisoft+monofilament+debridement+pad+for+use+un+acute+or+chronic+wounds+(MTG+17)+(2014)

Meaume S., Facy O., Munoz-Bongrand N. Cavity wounds management: a multicentre pilot study. Br J Nurs. 2013; 22:(15)S27-34

Trudigan J., Law P., Tarbox B. Evaluation of UrgoClean® for the treatment of sloughy, exuding wounds. Wounds UK. 2014; 10:(1)56-62

Himel H. Wound Healing: focus on the chronic wound. Wounds - A Compendium of Clinical Research and Practice. 1995; 5:A70-77

Wounds International International Best Practice: Best Practice Guidelines: Wound Management in Diabetic Foot Ulcers.: Wounds International; 2013

International consensus: Optimising wellbeing in people living with a wound. An expert working group review. 2012. https://www.researchgate.net/publication/230560329_International_consensus_Optimising_wellbeing_in_people_living_with_a_wound_An_expert_working_group_review

Sen C.K., Gordillo G.M., Roy S Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen. 2009; 17:(6)763-71

Robson M.C. Advancing the science of wound bed preparation for chronic wounds. Ostomy Wound Manage. 2012; 58:(11)10-12

Wound bed preparation: the importance of rapid and effective desloughing to promote healing

02 October 2017
Volume 1 · Issue 4

Abstract

This article describes effective ways of diagnosing and removing slough from a wound bed. It highlights how slough is a key contributor to wound chronicity, and gives practical clinical information on how to address this. The various methods of removing slough will be discussed including the mechanism of action of dressings and other mechanical methods. The ultimate objective of the article is to put the term, desloughing on the clinical agenda and increase clinicians’ familiarity with it. The practical focus of the article will help clinicians select a proven method to facilitate the rapid removal of slough. It is hoped that in doing so this will help to prevent chronicity, reduce the potential for bacterial proliferation and promote rapid and effective wound healing.

Chronic wounds such as venous leg ulcers have an underlying pathogenesis that contributes to the build-up of devitalised tissue. While it is vital to address the underlying pathology, it is essential to effectively remove devitalised tissue.1Removal of slough and dead tissue is imperative for successful wound management, with some authors claiming that healing is compromised without it.2,3 Shultz et al.1 argued that the presence of devitalised tissue increases the risk of wound infection, osteomyelitis, sepsis, protein depletion and delays healing. The devitalised tissue also limits the ability to visualise the base of the wound and measure or estimate its depth.

Literature frequently refers to slough and necrotic tissue under the umbrella term of devitalised tissue. However, this article evaluates the evidence on slough alone. This is based on the premise that, given the differences in the formation, manifestations and treatment of slough and necrotic tissue, the two can be studied and considered separately. The causes and constituents of slough are explained, along with its links with the inflammatory phase of wound healing and why slough is an ideal environment for bacterial proliferation. The article also addresses the relationship between slough and biofilm development/proliferation and wound chronicity. Finally, it emphasises that the rapid and selective removal of slough can avoid these deleterious effects, thereby promoting efficient wound healing and improved patient outcomes.

Register now to continue reading

Thank you for visiting Wound Central and reading some of our peer-reviewed resources for wound care professionals. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Access to clinical or professional articles

  • New content and clinical updates each month